Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Takei

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Hormones & Cancer|October 26, 2012
Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinomaKiyoshi Takagi, Takuya Moriya, Masafumi Kurosumi, et al.
BMC Cancer|March 18, 2016
Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapyTakayuki Ueno, Shigehira Saji, Masahiro Sugimoto, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2002
Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in JapanJun Horiguchi, Yuichi Iino, Yukio Koibuchi, et al.
International Journal of Legal Medicine|June 16, 2023
Postmortem genetic analysis of 17 sudden cardiac deaths identified nonsense and frameshift variants in two cases of arrhythmogenic cardiomyopathyYoichiro Takahashi, Haruki Fukuda, Akira Hayakawa, et al.
Cancers|July 2, 2021
Magnetically Guided Localization Using a Guiding-Marker System<sup>®</sup> and a Handheld Magnetic Probe for Nonpalpable Breast Lesions: A Multicenter Feasibility Study in JapanTomoko Kurita, Kanae Taruno, Seigo Nakamura, et al.
Breast Cancer (Tokyo, Japan)|May 21, 2020
Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)Hitoshi Tsuda, Koichiro Tsugawa, Futoshi Akiyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2023
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III TrialTakuji Iwase, Shigehira Saji, Kotaro Iijima, et al.
Cancer Science|January 15, 2011
Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibitionMasakazu Toi, Shigehira Saji, Norikazu Masuda, et al.
Nature Cell Biology|February 10, 2009
The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathwaysMasashi Kajiro, Ryuichi Hirota, Yuka Nakajima, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 9, 2019
Magnetically Promoted Rapid Immunofluorescence Staining for Frozen Tissue SectionsTatsuya Onishi, Sachiko Matsuda, Yuki Nakamura, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Hormones & Cancer|October 26, 2012
Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinomaKiyoshi Takagi, Takuya Moriya, Masafumi Kurosumi, et al.
BMC Cancer|March 18, 2016
Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapyTakayuki Ueno, Shigehira Saji, Masahiro Sugimoto, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2002
Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in JapanJun Horiguchi, Yuichi Iino, Yukio Koibuchi, et al.
International Journal of Legal Medicine|June 16, 2023
Postmortem genetic analysis of 17 sudden cardiac deaths identified nonsense and frameshift variants in two cases of arrhythmogenic cardiomyopathyYoichiro Takahashi, Haruki Fukuda, Akira Hayakawa, et al.
Cancers|July 2, 2021
Magnetically Guided Localization Using a Guiding-Marker System<sup>®</sup> and a Handheld Magnetic Probe for Nonpalpable Breast Lesions: A Multicenter Feasibility Study in JapanTomoko Kurita, Kanae Taruno, Seigo Nakamura, et al.
Breast Cancer (Tokyo, Japan)|May 21, 2020
Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)Hitoshi Tsuda, Koichiro Tsugawa, Futoshi Akiyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2023
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III TrialTakuji Iwase, Shigehira Saji, Kotaro Iijima, et al.
Cancer Science|January 15, 2011
Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibitionMasakazu Toi, Shigehira Saji, Norikazu Masuda, et al.
Nature Cell Biology|February 10, 2009
The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathwaysMasashi Kajiro, Ryuichi Hirota, Yuka Nakajima, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 9, 2019
Magnetically Promoted Rapid Immunofluorescence Staining for Frozen Tissue SectionsTatsuya Onishi, Sachiko Matsuda, Yuki Nakamura, et al.
Pageof 18